Our portfolio

Flowsure

Flowsure automates urine output monitoring in hospitalized patients with catheters. By combining a low-cost, reusable hardware device with integrated software, Flowsure eliminates the need for manual measurements and data entry, improving nursing efficiency and ensuring real-time, accurate data flow into the Electronic Health Record (EHR).

This enables earlier detection of complications like sepsis or hemorrhagic shock and supports personalized therapy adjustments, particularly in heart failure care.

Industry: Medical Technology

Want to get in contact about Flowsure?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Cellagenics

Scaling up therapeutic antibody production with STEP® technology.
Developing advanced machine learning and deep learning technologies, Scyfer specializes in applying these solutions across various industries, including industry, media, and healthcare.
Developing novel treatments for Parkinson’s disease and dopamine disorders.
Upcycling phosphate waste into sustainable industrial products.

Cellagenics

Scaling up therapeutic antibody production with STEP® technology.
Developing advanced machine learning and deep learning technologies, Scyfer specializes in applying these solutions across various industries, including industry, media, and healthcare.
Developing novel treatments for Parkinson’s disease and dopamine disorders.
Upcycling phosphate waste into sustainable industrial products.